NCT01539356

Hepcidin Levels in Preterm Infants

Hepcidin Levels in Preterm Infants Receiving Blood Transfusion and During Sepsis.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 62 (actual)
• Sponsor: Meir Medical Center · Academic / Other
• Sex: All
• Age: 24 Weeks – 37 Weeks
• Healthy volunteers: Not accepted

Summary

A recently isolated peptide hormone, hepcidin, is thought to be the principal regulator of iron homeostasis. Hepcidin acts by limiting intestinal iron absorption and promoting iron retention in reticuloendothelial cells. The aims of this study were to determine serum hepcidin levels in preterm infants who receive blood transfusion and preterm infants having sepsis, in order to assess possible relationships between hepcidin and serum iron, serum ferritin,in iron load situations.

Conditions

• Preterm Infants
• Anemia of Prematurity
• Neonatal Sepsis

Timeline

• Start date: 2012-03-01
• Primary completion: 2013-02-01
• Completion: 2013-08-01
• First posted: 2012-02-27
• Last updated: 2016-03-16

Locations

1 site across 1 country: Israel